Pulnovo Medical Announces Strategic Investment from Medtronic in oversubscribed $100 Million Financing Round
NEW YORK, April 20, 2026 /PRNewswire/ -- Pulnovo Medical, a pioneer in breakthrough therapies for treating Pulmonary Hypertension and Heart Failure, today announced the successful completion of an oversubscribed $100 million strategic financing...
Hydrexia Inks Hydrogen Commercial Contract in Vietnam
KUALA LUMPUR, Malaysia, April 13, 2026 /PRNewswire/ -- Hydrexia SDN BHD, a wholly owned company by Hydrexia Holding Limited (Hydrexia), a leading integrated hydrogen solution provider and KPT Chemical Group (KPT), a leading provider of environmental...